> top > projects > semrep-sample > docs > PubMed:10383397 > annotations
semrep-sample Home  

PubMed:10383397 JSONTXT 32 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
E1-ti-1 0-16 cui:C0047329 denotes 3-deazaadenosine
E2-ti-1 20-52 cui:C0050795 denotes S-adenosylhomocysteine hydrolase
E3-ti-1 53-62 cui:C0243077 denotes inhibitor
E4-ti-1 73-80 cui:C1280500 denotes effects
E5-ti-1 84-93 cui:C0521447 denotes NF-kappaB
E6-ti-1 84-93 cui:C1521761 denotes NF-kappaB
E7-ti-1 94-104 cui:C0851285 denotes regulation
T1 106-116 DISRUPTS denotes Inhibition
E1-ti-2 120-129 cui:C0521447 denotes NF-kappaB
E2-ti-2 120-129 cui:C1521761 denotes NF-kappaB
E3-ti-2 130-145 cui:C0040649 denotes transcriptional
E4-ti-2 146-154 cui:C0439167 denotes activity
E5-ti-2 159-168 cui:C0033414 denotes promotion
E6-ti-2 172-184 cui:C0126732 denotes IkappaBalpha
E7-ti-2 185-196 cui:C0243125 denotes degradation
E1-ab-1 226-242 cui:C0047329 denotes 3-deazaadenosine
E2-ab-1 252-258 cui:C0237399 denotes potent
E3-ab-1 259-268 cui:C0243077 denotes inhibitor
E4-ab-1 287-319 cui:C0050795 denotes S-adenosylhomocysteine hydrolase
T2 320-328 INHIBITS denotes inhibits
T3 320-328 INHIBITS denotes inhibits
E5-ab-1 329-338 cui:C0521009 denotes bacterial
E6-ab-1 339-357 cui:C0023810 denotes lipopolysaccharide
E7-ab-1 358-365 cui:C0205263 denotes induced
E8-ab-1 366-379 cui:C0040649 denotes transcription
E9-ab-1 383-410 cui:C1448177 denotes tumor necrosis factor-alpha
E10-ab-1 415-432 cui:C0021753 denotes interleukin-1beta
T4 433-435 LOCATION_OF denotes in
T5 433-435 LOCATION_OF denotes in
E11-ab-1 436-441 cui:C0025914 denotes mouse
E12-ab-1 442-452 cui:C0024432 denotes macrophage
E13-ab-1 463-468 cui:C0007634 denotes cells
E1-ab-2 478-483 cui:C0008972 denotes study
E2-ab-2 504-511 cui:C1280500 denotes effects
E3-ab-2 515-518 cui:C0041286 denotes DZA
E4-ab-2 522-529 cui:C0521447 denotes nuclear
E5-ab-2 530-536 cui:C1521761 denotes factor
E6-ab-2 556-566 cui:C0851285 denotes regulation
E1-ab-3 568-571 cui:C0041286 denotes DZA
T6 572-580 DISRUPTS denotes inhibits
E2-ab-3 585-600 cui:C0040649 denotes transcriptional
E3-ab-3 601-609 cui:C0439167 denotes activity
E4-ab-3 613-622 cui:C0521447 denotes NF-kappaB
E5-ab-3 613-622 cui:C1521761 denotes NF-kappaB
E6-ab-3 648-651 cui:C0599933 denotes p65
E7-ab-3 653-656 cui:C0751998 denotes Rel
E8-ab-3 660-675 cui:C0031715 denotes phosphorylation
T7 684-693 DISRUPTS denotes reduction
E9-ab-3 701-722 cui:C1518440 denotes nuclear translocation
E10-ab-3 727-738 cui:C1148673 denotes DNA binding
E11-ab-3 739-747 cui:C0439167 denotes activity
E1-ab-4 753-763 cui:C0243077 denotes inhibitory
E2-ab-4 764-770 cui:C1280500 denotes effect
T8 764-770 AFFECTS denotes effect
E3-ab-4 774-777 cui:C0041286 denotes DZA
E4-ab-4 781-790 cui:C0521447 denotes NF-kappaB
E5-ab-4 781-790 cui:C1521761 denotes NF-kappaB
E6-ab-4 791-806 cui:C0040649 denotes transcriptional
E7-ab-4 807-815 cui:C0439167 denotes activity
E8-ab-4 838-846 cui:C0442796 denotes addition
E9-ab-4 850-862 cui:C0019878 denotes homocysteine
E1-ab-5 880-883 cui:C0041286 denotes DZA
T9 884-892 STIMULATES denotes promotes
E2-ab-5 897-908 cui:C0030946 denotes proteolytic
E3-ab-5 909-920 cui:C0243125 denotes degradation
E4-ab-5 924-936 cui:C0126732 denotes IkappaBalpha
E5-ab-5 942-945 cui:C1518422 denotes not
E6-ab-5 946-957 cui:C0166033 denotes IkappaBbeta
E7-ab-5 975-983 cui:C0442805 denotes increase
T10 975-983 AUGMENTS denotes increase
E8-ab-5 987-998 cui:C1148673 denotes DNA binding
E9-ab-5 999-1007 cui:C0439167 denotes activity
E10-ab-5 1011-1020 cui:C0521447 denotes NF-kappaB
E11-ab-5 1011-1020 cui:C1521761 denotes NF-kappaB
E12-ab-5 1058-1073 cui:C0040649 denotes transcriptional
E13-ab-5 1074-1082 cui:C0439167 denotes activity
T11 1083-1085 LOCATION_OF denotes in
E14-ab-5 1096-1101 cui:C0007634 denotes cells
E1-ab-6 1120-1132 cui:C0126732 denotes IkappaBalpha
E2-ab-6 1136-1139 cui:C0041286 denotes DZA
E3-ab-6 1163-1177 cui:C0663914 denotes IkappaB kinase
E4-ab-6 1178-1185 cui:C0439855 denotes complex
T12 1201-1210 INTERACTS_WITH denotes modulated
E5-ab-6 1218-1226 cui:C0442796 denotes addition
E6-ab-6 1230-1242 cui:C0019878 denotes homocysteine
E1-ab-7 1249-1254 cui:C0008972 denotes study
E2-ab-7 1278-1281 cui:C0041286 denotes DZA
T13 1278-1302 ISA denotes DZA may be a potent drug
T16 1278-1302 TREATS denotes DZA may be a potent drug
E3-ab-7 1291-1297 cui:C0237399 denotes potent
E4-ab-7 1298-1302 cui:C0013227 denotes drug
E5-ab-7 1311-1320 cui:C0087111 denotes treatment
T14 1311-1320 TREATS denotes treatment
E6-ab-7 1324-1332 cui:C0012634 denotes diseases
E7-ab-7 1342-1351 cui:C0521447 denotes NF-kappaB
E8-ab-7 1342-1351 cui:C1521761 denotes NF-kappaB
E9-ab-7 1360-1367 cui:C0205099 denotes central
E10-ab-7 1368-1378 cui:C1136169 denotes pathogenic
E11-ab-7 1379-1383 cui:C0035820 denotes role
T15 1379-1383 ASSOCIATED_WITH denotes role
E12-ab-7 1405-1409 cui:C0336791 denotes tool
E13-ab-7 1414-1422 cui:C0008972 denotes studying
E14-ab-7 1427-1437 cui:C0851285 denotes regulation
E15-ab-7 1442-1465 cui:C1254359 denotes physiological functions
E16-ab-7 1469-1478 cui:C0521447 denotes NF-kappaB
E17-ab-7 1469-1478 cui:C1521761 denotes NF-kappaB
R1 E6-ti-2 T1 subjectOf IkappaBalpha,Inhibition
R10 E9-ab-1 T5 objectOf tumor necrosis factor-alpha,in
R11 E1-ab-3 T6 subjectOf DZA,inhibits
R12 E2-ab-3 T6 objectOf transcriptional,inhibits
R13 E7-ab-3 T7 subjectOf Rel,reduction
R14 E9-ab-3 T7 objectOf nuclear translocation,reduction
R15 E3-ab-4 T8 subjectOf DZA,effect
R16 E6-ab-4 T8 objectOf transcriptional,effect
R17 E1-ab-5 T9 subjectOf DZA,promotes
R18 E2-ab-5 T9 objectOf proteolytic,promotes
R19 E6-ab-5 T10 subjectOf IkappaBbeta,increase
R2 E3-ti-2 T1 objectOf transcriptional,Inhibition
R20 E8-ab-5 T10 objectOf DNA binding,increase
R21 E14-ab-5 T11 subjectOf cells,in
R22 E4-ab-5 T11 objectOf IkappaBalpha,in
R23 E2-ab-6 T12 subjectOf DZA,modulated
R24 E6-ab-6 T12 objectOf homocysteine,modulated
R25 E2-ab-7 T13 subjectOf DZA,DZA may be a potent drug
R26 E4-ab-7 T13 objectOf drug,DZA may be a potent drug
R27 E4-ab-7 T14 subjectOf drug,treatment
R28 E6-ab-7 T14 objectOf diseases,treatment
R29 E10-ab-7 T15 subjectOf pathogenic,role
R3 E4-ab-1 T2 subjectOf S-adenosylhomocysteine hydrolase,inhibits
R30 E6-ab-7 T15 objectOf diseases,role
R31 E2-ab-7 T16 subjectOf DZA,DZA may be a potent drug
R32 E6-ab-7 T16 objectOf diseases,DZA may be a potent drug
R4 E9-ab-1 T2 objectOf tumor necrosis factor-alpha,inhibits
R5 E4-ab-1 T3 subjectOf S-adenosylhomocysteine hydrolase,inhibits
R6 E10-ab-1 T3 objectOf interleukin-1beta,inhibits
R7 E13-ab-1 T4 subjectOf cells,in
R8 E10-ab-1 T4 objectOf interleukin-1beta,in
R9 E13-ab-1 T5 subjectOf cells,in